Takeda initiates development of Plasma-Derived Therapy for COVID-19

Japan based Takeda Pharmaceutical Company will share with members of the United States Congress that it is initiating th...

March 5, 2020 | Thursday | News
Eisai, FUJI YAKUHIN to work on hyperuricemia and gout treatment

Japan based Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD.  have concluded a license agreement concerning dotinurad (ge...

February 27, 2020 | Thursday | News
Arctoris launches BioTarget 2020 to support biotech company innovations

Arctoris Ltd, an Oxford-based company that operates the world’s first fully automated drug discovery platform, has...

February 21, 2020 | Friday | News
Codagenix & Serum Institute to co-develop vaccine against Novel Coronavirus

Codagenix, Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies h...

February 14, 2020 | Friday | News
China's Borui Biomedical imitates Gilead's Coronavirus drug

Borui Bio-Pharmaceutical (Suzhou) Co., Ltd. announced that it has successfully developed and synthesizes the technology ...

February 14, 2020 | Friday | News
Gilead begins trial for coronavirus drug

US based biotech company Gilead is working with health authorities in China to establish a randomized, controlled trial ...

February 12, 2020 | Wednesday | News
Bridge Biotherapeutics acquires new candidate for back-eye diseases

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea has acquired ...

February 6, 2020 | Thursday | News
Astellas submits sNDA in Japan for Evrenzo to treat Anemia

Astellas Pharma Inc. and FibroGen, Inc. has announced the submission of a supplemental New Drug Application (sNDA) to&nb...

January 30, 2020 | Thursday | News
Noxopharm to transform cancer treatment space

Headquartered in Australia, Noxopharm Limited is a clinical stage drug development company that has been in the limeligh...

January 29, 2020 | Wednesday | News
PerkinElmer unveils Advanced Drug Discovery and Disease Research Solutions

PerkinElmer, Inc., a global leader committed to innovating for a healthier world,  introduced new workstations...

January 28, 2020 | Tuesday | News
CEPI selects Inovio to develop vaccine against coronavirus

US based Inovio Pharmaceuticals, has announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded In...

January 28, 2020 | Tuesday | News
Darolutamide gets marketing authorization in Japan

The Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authorization for darolutamide, under th...

January 24, 2020 | Friday | News
RegeneRx Biopharma receives patent in Korea

US based RegeneRx Biopharmaceuticals, a clinical-stage drug development company focused on tissue protection, repai...

January 23, 2020 | Thursday | News
Hitachi Chemical inks pact with Ori Biotech

Hitachi Chemical Advanced Therapeutics Solutions, LLC,  a US subsidiary of Japanese firm Hitachi Chemical Co., Ltd....

January 23, 2020 | Thursday | News
PhoreMost, Otsuka collaborate for multi drug discovery projects

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease target...

January 22, 2020 | Wednesday | News
ViiV Healthcare wins Japanese approval for Dovato to treat HIV-1

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as share...

January 20, 2020 | Monday | News
InterVenn Biosciences advances glycoproteomics for complex disease therapies

US based InterVenn Biosciences has announced multiple achievements in its development of AI-enabled glycoproteomics, as ...

January 17, 2020 | Friday | News
Charles River inks scientific collaboration with Takeda

US based company Charles River has announced a multi-year drug discovery collaboration with Japanese firm Takeda Pharmac...

January 16, 2020 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls